IMDX
Insight Molecular Diagnostics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.00
+1.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 74.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -6.15x
- Price / sales
- 78.38x
- Price / cash flow
- -4.86x
Enterprise value
- Enterprise value
- $115.8M
- EV / sales
- 69.32x
- EV / EBITDA
- -2.47x
- EV / EBIT
- -2.71x
- Market cap
- $130.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026